Liposomal Bupivacaine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064674
  • May 2021
  • Pharmaceuticals
  • 125 Pages
The Liposomal Bupivacaine market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Liposomal Bupivacaine market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Merck and Co., Cipla, Inc., Cadila Pharmaceuticals, SRS Pharmaceuticals Pvt. Ltd., EXPAREL, Pacira
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Liposomal Bupivacaine market along with their effects over the forecast period. Similarly, according to the region Liposomal Bupivacaine market research report includes the study of opportunities available in the market situation.

The Liposomal Bupivacaine market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Liposomal Bupivacaine Market:
The Liposomal Bupivacaine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Sun Pharmaceutical Industries Ltd., Johnson and Johnson, Merck and Co., Cipla, Inc., Cadila Pharmaceuticals, SRS Pharmaceuticals Pvt. Ltd., EXPAREL, Pacira

Liposomal Bupivacaine Market Segmentation Analysis:
By Type
20ml
10ml
Application
Veterinary
Human

Global Liposomal Bupivacaine Market Segmentation by Regions:
In regional analysis, Liposomal Bupivacaine market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Liposomal Bupivacaine market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Liposomal Bupivacaine Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Liposomal Bupivacaine Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Liposomal Bupivacaine Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Liposomal Bupivacaine Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Liposomal Bupivacaine Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Liposomal Bupivacaine market, according to the key region.
  • To study the Liposomal Bupivacaine market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Liposomal Bupivacaine market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Liposomal Bupivacaine research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Liposomal Bupivacaine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Liposomal Bupivacaine market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Liposomal Bupivacaine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Liposomal Bupivacaine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Liposomal Bupivacaine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Sun Pharmaceutical Industries Ltd.
  • Johnson and Johnson
  • Merck and Co.
  • Cipla, Inc.
  • Cadila Pharmaceuticals
  • SRS Pharmaceuticals Pvt. Ltd.
  • EXPAREL
  • Pacira
  • 20ml
  • 10ml
  • Veterinary
  • Human

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Liposomal Bupivacaine Market Snapshot
          2.1.1. Global Liposomal Bupivacaine Market By Type,2019
               2.1.1.1.20ml
               2.1.1.2.10ml
          2.1.2. Global Liposomal Bupivacaine Market By Application,2019
               2.1.2.1.Veterinary
               2.1.2.2.Human
          2.1.3. Global Liposomal Bupivacaine Market By End-use,2019
          2.1.4. Global Liposomal Bupivacaine Market By Geography,2019

3. Global Liposomal Bupivacaine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028

5. Global Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028

6. Global Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028

7. Global Liposomal Bupivacaine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Liposomal Bupivacaine Market Analysis, 2018 – 2028 
          7.2.1. North America Liposomal Bupivacaine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Liposomal Bupivacaine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Liposomal Bupivacaine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Liposomal Bupivacaine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Liposomal Bupivacaine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Liposomal Bupivacaine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Liposomal Bupivacaine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Liposomal Bupivacaine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Liposomal Bupivacaine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Liposomal Bupivacaine Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Liposomal Bupivacaine Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Liposomal Bupivacaine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Liposomal Bupivacaine Providers
        8.4.1 Sun Pharmaceutical Industries Ltd.
                8.4.1.1 Business Description
                8.4.1.2 Sun Pharmaceutical Industries Ltd. Geographic Operations
                8.4.1.3 Sun Pharmaceutical Industries Ltd. Financial Information
                8.4.1.4 Sun Pharmaceutical Industries Ltd. Product Positions/Portfolio
                8.4.1.5 Sun Pharmaceutical Industries Ltd. Key Developments
        8.4.2 Johnson and Johnson
                8.4.2.1 Business Description
                8.4.2.2 Johnson and Johnson Geographic Operations
                8.4.2.3 Johnson and Johnson Financial Information
                8.4.2.4 Johnson and Johnson Product Positions/Portfolio
                8.4.2.5 Johnson and Johnson Key Developments
        8.4.3 Merck and Co.
                8.4.3.1 Business Description
                8.4.3.2 Merck and Co. Geographic Operations
                8.4.3.3 Merck and Co. Financial Information
                8.4.3.4 Merck and Co. Product Positions/Portfolio
                8.4.3.5 Merck and Co. Key Developments
        8.4.4 Cipla, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Cipla, Inc. Geographic Operations
                8.4.4.3 Cipla, Inc. Financial Information
                8.4.4.4 Cipla, Inc. Product Positions/Portfolio
                8.4.4.5 Cipla, Inc. Key Developments
        8.4.5 Cadila Pharmaceuticals
                8.4.5.1 Business Description
                8.4.5.2 Cadila Pharmaceuticals Geographic Operations
                8.4.5.3 Cadila Pharmaceuticals Financial Information
                8.4.5.4 Cadila Pharmaceuticals Product Positions/Portfolio
                8.4.5.5 Cadila Pharmaceuticals Key Developments
        8.4.6 SRS Pharmaceuticals Pvt. Ltd.
                8.4.6.1 Business Description
                8.4.6.2 SRS Pharmaceuticals Pvt. Ltd. Geographic Operations
                8.4.6.3 SRS Pharmaceuticals Pvt. Ltd. Financial Information
                8.4.6.4 SRS Pharmaceuticals Pvt. Ltd. Product Positions/Portfolio
                8.4.6.5 SRS Pharmaceuticals Pvt. Ltd. Key Developments
        8.4.7 EXPAREL
                8.4.7.1 Business Description
                8.4.7.2 EXPAREL Geographic Operations
                8.4.7.3 EXPAREL Financial Information
                8.4.7.4 EXPAREL Product Positions/Portfolio
                8.4.7.5 EXPAREL Key Developments
        8.4.8 Pacira
                8.4.8.1 Business Description
                8.4.8.2 Pacira Geographic Operations
                8.4.8.3 Pacira Financial Information
                8.4.8.4 Pacira Product Positions/Portfolio
                8.4.8.5 Pacira Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Liposomal Bupivacaine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Liposomal Bupivacaine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Liposomal Bupivacaine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Liposomal Bupivacaine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Liposomal Bupivacaine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Liposomal Bupivacaine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Liposomal Bupivacaine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Liposomal Bupivacaine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Liposomal Bupivacaine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Liposomal Bupivacaine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Liposomal Bupivacaine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Liposomal Bupivacaine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Liposomal Bupivacaine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Liposomal Bupivacaine Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Liposomal Bupivacaine Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Liposomal Bupivacaine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Liposomal Bupivacaine: Market Segmentation 
FIG. 2 Global Liposomal Bupivacaine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Liposomal Bupivacaine Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Liposomal Bupivacaine Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Liposomal Bupivacaine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Liposomal Bupivacaine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Liposomal Bupivacaine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Liposomal Bupivacaine Providers, 2019
FIG. 11 Global Liposomal Bupivacaine Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Liposomal Bupivacaine Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Liposomal Bupivacaine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Liposomal Bupivacaine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Liposomal Bupivacaine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Liposomal Bupivacaine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Liposomal Bupivacaine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Liposomal Bupivacaine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Liposomal Bupivacaine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Liposomal Bupivacaine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Liposomal Bupivacaine Market Value, By Segment1, 2018 – 2028
TABLE  North America Liposomal Bupivacaine Market Value, By Segment2, 2018 – 2028
TABLE  North America Liposomal Bupivacaine Market Value, By Country, 2018 – 2028
TABLE  Europe Liposomal Bupivacaine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Liposomal Bupivacaine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Liposomal Bupivacaine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Liposomal Bupivacaine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Liposomal Bupivacaine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Liposomal Bupivacaine Market Value, By Country, 2018 – 2028
TABLE  Latin America Liposomal Bupivacaine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Liposomal Bupivacaine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Liposomal Bupivacaine Market Value, By Country, 2018 – 2028
TABLE  MEA Liposomal Bupivacaine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Liposomal Bupivacaine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Liposomal Bupivacaine Market Value, By Country, 2018 – 2028
TABLE  Sun Pharmaceutical Industries Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Johnson and Johnson: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Co.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cipla, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cadila Pharmaceuticals: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  SRS Pharmaceuticals Pvt. Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  EXPAREL: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pacira: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Liposomal Bupivacaine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Liposomal Bupivacaine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Liposomal Bupivacaine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Liposomal Bupivacaine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Liposomal Bupivacaine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Liposomal Bupivacaine Providers, 2016
FIG.  Global Liposomal Bupivacaine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global 10ml Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Liposomal Bupivacaine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Human Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Liposomal Bupivacaine Market Value, 2018 – 2028, (US$ Mn)